Abstract
Cysteine dioxygenase (CDO), structurally resembles cupin enzymes that use a 3-His/1-Glu coordination scheme. However, the glutamate ligand is substituted with a cysteine (Cys93) residue, which forms a thioether bond with tyrosine (Tyr157) under physiological conditions. The reversion variant, C93E CDO, was generated to reestablish the more common 3-His/1-Glu metal ligands of the cupin superfamily. This variant provides a framework to test the structural and functional significance of Cys93 and the crosslink in CDO. Although dioxygen consumption is observed with C93E CDO, it was not coupled with L-cysteine oxidation. Substrate analogs (D-cysteine, cysteamine, 3-mercaptopropionate) were not viable substrates for the C93E CDO variant, although they showed variable coordination to the iron center. The structures of C93E, crosslinked and non-crosslinked wild-type CDO were solved by X-ray crystallography to 1.91 Å, 2.49 Å, and 2.30 Å, respectively. The C93E CDO variant had similar overall structural properties as crosslinked CDO, but the iron was coordinated by a 3-His/1-Glu geometry leaving only two coordination sites available for dioxygen and bidentate L-cysteine binding. The hydroxyl group of Tyr157 shifted in both non-crosslinked and C93E CDO, and this displacement prevents this residue from participation in substrate stabilization. Based on these results, divergence of the metal center of cysteine dioxygenase from the 3-His/1-Glu geometry seen with many cupin enzymes was essential for effective substrate binding. Substitution of Glu with Cys in CDO allows for a third coordination site on the iron for bidentate cysteine and monodentate oxygen binding.
Introduction
Cysteine dioxygenase is an iron-dependent enzyme that catalyzes the conversion of L-cysteine to cysteine sulfinic acid (Scheme 1).1,2 Unlike L-cysteine, cysteine sulfinic acid (CSA) is not itself a metabolically significant molecule. Instead, CSA serves as a major branch point in the catabolism of cysteine in mammals, and is further metabolized to pyruvate and sulfite or taurine.1,2
Scheme 1.
CDO reaction.
Cysteine dioxygenase belongs to the cupin superfamily, which is characterized by a double-stranded P-helix (DSBH) (Figure 1A).3–5 The DSBH fold typically consists of six to eight beta sheets that fold in half creating a sandwich-like casing around the active site.6 While some enzymes, including CDO, contain a coordinated iron, other cupin enzymes possess a nickel, zinc, manganese, cobalt, or copper metal center.1,7–12 These different metal cofactors allow for the diverse enzyme activities observed within this family that include isomerase, decarboxylase, dioxygenase, cyclase, and epimerase reactions. Proposed reaction mechanisms of the metal-dependent cupins generally involve sequential binding of the substrate and dioxygen to the catalytic metal cation.
Figure 1.
Overall structure and metal coordination motifs of cupin enzymes. A. CDO exhibits a β-barrel fold characteristic of the cupin superfamily (PDB: 6U4S). B. Acireductone dioxygenase has a characteristic 3 His/1 Glu coordination metal center (PDB: 2HJI).14 C. The 3-His iron coordination motif of CDO is shown. A thioether crosslink between C93 and Y157 is positioned near the iron center (PDB: 6U4S). Ferric iron are shown as yellow spheres, and water molecules are red spheres.
The enzymatic cupins were initially characterized by two conserved sequence motifs, GX5HXHX3–6EX6G and GX5–7PXGX2HX3N, containing the amino acid ligands that coordinate the metal (highlighted in bold).6,13 Metals in enzymatic cupins are often coordinated by 3-His and 1-Glu located within the two conserved motifs (Figure 1B).14 The 3-His/1-Glu ligand occupies four coordination sites with solvent molecules occupying the remaining sites. A nitrogen of each histidine coordinates monodentate to the metal, while the glutamate coordinates the metal by the Os-1 atom oxygen of the carboxyl group. In enzymatic cupins, the resting state of the metal center can exhibit different geometries, including octahedral, tetrahedral, trigonal bipyramidal, and square pyramidal geometries.4,5,9,15,16 However, the substrate bound metal cation often exhibits octahedral geometry, allowing for a total of six coordination sites.
The active site of cysteine dioxygenase contains a modification to the common 3-His/1-Glu cupin motif. The glutamate residue is replaced by a noncoordinating cysteine (Cys93), leaving iron weakly coordinated by three histidine residues. Interestingly, the noncoordinating cysteine residue forms a thioether bond with a nearby tyrosine (Tyr157) residue (Figure 1C). Wild-type rat CDO heterologously expressed in E. coli exists as an approximate equal mixture of non-crosslinked and crosslinked isoforms.17,18 These isoforms resolve on SDS-PAGE as two distinct bands with the non-crosslinked isoform representing the upper molecular weight band.19,20 While the Cys-Tyr crosslink is not required for product formation, the crosslink enhances catalytic efficiency.20,21 There have been several proposed roles for the thioether crosslink since the initial structural determination of CDO. Although not essential for catalysis, formation of the crosslink may properly position the hydroxyl group of Tyr157 for optimal substrate binding.5,20,22–25 It has been suggested that formation of the crosslink leads to a pre-ordered state for substrate binding.21 Additional studies suggest that the thioether crosslink may also prevent competing side reactions of Cys93.24,26
Alternative metal binding has been observed with proteins that comprise the cupin superfamily. Therefore, it is unclear how divergence of the metal center from a 3 His/1 Glu to a 3 His iron binding site affects the functional properties of the enzyme.27 Although studies have been performed to compare the 3-His coordination of CDO to the more conventional 2-His/1-Glu motif, there have been no direct studies to evaluate the catalytic benefit of the 3-His motif relative to the 3-His/1-Glu motif.28 Herein, the conserved Cys93 residue was replaced with glutamate to determine how the substitution alters the kinetic and structural properties of the enzyme compared to the wild-type enzyme. These studies were augmented with the first three-dimensional structure of non-crosslinked wild-type CDO to compare the position of Cys93 in the active site to the Glu substituted variant.
Materials and Methods
Materials
4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), L-cysteine, D-cysteine, cysteamine, 3-mercaptopropionic acid (3-MPA), L-ascorbate, ammonium sulfate, ampicillin, streptomycin sulfate, lysozyme, and brilliant blue R were purchased from Sigma (St. Louis, MO). Isopropyl-β-D-thiogalactoside (IPTG) was purchased from Gold Biotechnology (St. Louis, MO). Glycerol and sodium chloride were purchased from Macron Fine Chemicals (Center Valley, PA). Difco-brand Luria-Bertani (LB) media was purchased from Becton Dickinson and Company (Sparks, MD). Macro-Prep® High Q Support column media was purchased from Bio-Rad Laboratories (Hercules, CA).
Construction and purification of C93E CDO
The expression vector for rat C93E CDO was constructed through PCR amplification using 29 base oligonucleotide primers that replace the wild-type Cys codon with the Glu codon (GAA). The PCR product containing the Cys to Glu substitution was confirmed by DNA sequence analysis (Davis Sequencing, Davis, CA), and the C93E CDO vector was transformed into BL21 (DE3) competent E. coli cells and stored as 20% glycerol stock at −80 °C. Expression and purification of wild-type and C93E CDO was carried out as previously described.28 Expression of non-crosslinked wild-type CDO was carried out in the presence of 1,10-phenanthroline as previously described.21
Ferrozine was used to determine the amount of iron present as previously described with slight modifications.29 CDO samples (40 μM) were incubated at 95 °C for 5 minutes with ferrozine (250 μM) and ascorbate (18 mM). After 5 mins, sodium acetate (1.5 M) was added and the samples were measured at 562 nm. A standard curve (5–30 μM) was created using iron ICP standards and the standards were treated the same as the CDO samples. The results were based on the average of three separate experiments.
Circular dichroism
Protein samples were buffer exchanged with 10 mM potassium phosphate, pH 7.5, using a 10 000 kDa MWCO Amicon Ultra Centrifugal Filters (Millipore) at 5000 RPM, 4°C. Far-UV circular dichroism spectra were recorded on a JASCO J-810 spectropolarimeter. Spectra of wild-type and C93E CDO (10 μM) were taken in 0.1 nm increments in continuous scanning mode from 300 to 185 nm in a 0.1 cm cuvette with a bandwidth of 1 nm and scanning speed of 20 nm/min. Each spectra is an average of six scans. Background subtraction and smoothing of the data were performed using the software provided. Final data were plotted using KaleidaGraph™ software (Synergy Software, Reading, PA).
Steady-state kinetic analysis of wild-type and C93E CDO
Steady-state kinetic parameters were determined using a Clark-type oxygen electrode monitoring the rate of dioxygen utilization.28 Each assay contained a final concentration of 2 μM enzyme and 1 mM ascorbate in 25 mM HEPES, pH 7.5, at 37 °C. The assays were initiated by the addition of L-cysteine substrate (50 μM to 5 mM), and the initial velocities (nmol of oxygen consumed per second) were measured from the linear portion of the trace. The vo/[Et] was corrected for the amount of iron present and plotted against the substrate concentration. Steady-state kinetic parameters were determined by fitting the averaged data from four individual experiments to the Michaelis-Menten equation using KaleidaGraph™ software (Synergy Software, Reading, PA). Substrate analogs D-cysteine, cysteamine, and 3-MPA were also tested for dioxygen consumption and product formation using the same protocol.
Activity and product analysis of wild-type and C93E CDO
Cysteine sulfinic acid (CSA) or hypotaurine formation were quantified independently using mass spectrometry (MS) and correlated with the rate of dioxygen consumption. Assay conditions were similar to the dioxygen consumption assay, and reactions were initiated with the addition of 1 mM L-cysteine or cysteamine. After one minute the reaction was quenched with 1 μL formic acid (90% v/v). Acetonitrile was added to the quenched reaction in a 1:1 ratio (v/v). Mass analysis was performed on an Ultra Performance LC System (ACQUITY, Waters Corp., Milford, MA, USA) in-line with a quadrupole time-of-flight mass spectrometer (Q-Tof Premier, Waters) and electrospray ionization (ESI-MS) in negative mode. Cysteine sulfinic acid hypotaurine concentrations were determined against a CSA or hypotaurine standard curve which ranged from 50 – 200 μM (Figure 2).
Figure 2.
Structural analogs of L-cysteine: D-cysteine, cysteamine (2-aminoethanethiol), and 3-mercaptopropionic acid (3-MPA).
EPR spectroscopy
Electron paramagnetic resonance (EPR) studies were performed on a Bruker EMX spectrometer at X-band frequency (Bruker Biospin Corporation, Billerica, MA). Cooling to 9.8 K was performed using an Oxford Instruments ESR 900 flow cryostat and an ITC4 temperature controller. EPR analysis was performed with 100 μM CDO or C93E CDO as purified in 25 mM HEPES, 10% glycerol, pH 7.5, with 0.1 M NaCl. Samples containing a final concentration of 10 mM L-cysteine or substrate analogs (D-cysteine, cysteamine, and 3-MPA) were incubated with 100 μm enzyme on ice for 1 min and then flash frozen in EPR tubes with liquid nitrogen. All spectra were recorded using the following settings: 9.39 GHz microwave frequency, 1.99 mW microwave power, 2 × 104 or 4 × 104 receiver gain, 100 kHz modulation frequency, 6 G modulation amplitude, with a time constant of 163.84 ms, and a sweep time of 167.77 s.
Crystallization and diffraction data collection
Crystals were grown at 24°C using the hanging drop method. The reservoir solution for wild-type CDO contained 1 M lithium chloride, 22.5% (w/v) poly(ethylene glycol) (PEG) 10,000 in 0.1 M MES, pH 5.5, and the reservoir buffer for non-crosslinked wild-type CDO contained 1 M lithium chloride, 24% (w/v) poly(ethylene glycol) (PEG) 20,000 in 0.1 M MES at pH 6.5. Reservoir buffer of C93E CDO contained 1 M lithium chloride, 30% PEG 6,000 in 0.1 M sodium acetate. Each drop contained 1.5 μL of protein at 13 mg/ml for wild-type CDO or 11 mg/ml for non-crosslinked CDO in 50 mM Tris pH 8, 100 mM NaCl or 5 mg/ml C93E CDO in 25 mM HEPES pH 7.5, 100 mM NaCl 10% (v/v) glycerol mixed with an equal volume of reservoir solution. Drops containing wild-type and non-crosslinked wild-type CDO were microseeded immediately with 0.3 μL C93E CDO crystals in 1 M lithium chloride, 25% (w/v) PEG 6,000, 0.1 M MES, pH 5.5. Crystals were formed after one day and grew to full size within four days. For data collection, crystals were serially washed in 1 M lithium chloride, 30% PEG 6,000 in 0.1 M sodium acetate supplemented with 20% (w/v) sucrose as a cryoprotectant and flash cooled to - 160°C.
Wild-type CDO diffraction data (0.15° oscillation images for a total of 83°) were collected remotely at the Stanford Synchrotron Radiation Laboratory (SSRL, Stanford, CA) on beamline 12–2 at a wavelength of 0.9795 Å at 100 K using Blu-Ice.30 The exposure time per frame was 0.5 s with 79.5% attenuation and a crystal to detector distance of 344.6 mm. The data were indexed and scaled with XDS to 2.49 Å.31 The crystals were assigned to the space group P41212 with unit cell dimensions a = b = 57.5 Å and c = 122.3 Å (Table 1).
Table 1:
Data collection and refinement statistics for wild-type and C93E CDO
crosslinked CDO PDB: 6U4S |
non-crosslinked CDO PDB: 6U4V |
C93E CDO PDB: 6U4L |
|
---|---|---|---|
Data collectiona | |||
Beamline | 12–2 | 12–2 | 7–1 |
Wavelength (Å) | 0.9795 | 0.9795 | 1.1271 |
Space group | P41212 | P41212 | P41212 |
Cell dimensions: a, b, c (Å), β (°) | 57.5, 57.5, 122.3 | 57.6, 57.6, 122.5 | 57.7, 57.7, 122.2 |
Resolution (Å) | 38.6 – 2.49 | 38.6 – 2.30 | 38.7 – 1.91 |
(2.59 – 2.49) | (2.38 – 2.30) | (1.96 – 1.91) | |
Rmergeb | 0.082 (0.452) | 0.116 (0.459) | 0.085 (0.417) |
Total observations | 43530 (4665) | 75791 (6100) | 451694 (18259) |
Total unique observations | 7638 (809) | 9683 (857) | 16741 (1068) |
Mean ((I / sd(I)) | 13.5 (3.1) | 13.0 (4.2) | 33.4 (7.4) |
Completeness (%) | 99.2 (96.7) | 99.4 (94.2) | 99.9 (98.2) |
Redundancy | 5.7 (5.8) | 7.8 (7.1) | 27.0 (17.1) |
Refinement | |||
Resolution (Å) | 38.6 – 2.49 (2.68 – 2.49) | 38.6 – 2.30 (2.42 – 2.30) | 38.7 – 1.91 (1.97 – 1.91) |
(2.68 – 2.49) | (2.42 – 2.30) | (1.97 – 1.91) | |
Rcrystc | 0.178 (0.230) | 0.175 (0.194) | 0.174 (0.176) |
Rfree | 0.261 (0.327) | 0.233 (0.315) | 0.215 (0.239) |
Total unique observations | 7599 (1307) | 9435 (1098) | 16517 (1154) |
No. of non-hydrogen atoms | |||
Protein | 1502 | 1502 | 1481 |
Iron | 1 | 1 | 1 |
Ligand | 0 | 0 | 4 |
Water | 5 | 19 | 84 |
rms deviation bonds (Å) | 0.015 | 0.013 | 0.01 |
rms deviation angles (°) | 1.28 | 1.14 | 1.04 |
Overall mean B-factor (Å2) | 36.9 | 20.5 | 18.4 |
Ramachandran plot analysisd | |||
Favored region | 97.81 | 99.45 | 99.44 |
Allowed region | 2.19 | 0.55 | 0.56 |
Outlier region | 0.00 | 0.00 | 0.00 |
data indexed and scaled with XDS
Rmerge = Σh|Ih - <I>|/ΣhIh, where Ih is the intensity of reflection h, and <I> is the mean intensity of all symmetry-related
Rcryst = Σ||F0| - |Fc||/Σ|Fo|, Fo and Fc are observed and calculated structure factor amplitudes. Five percent of the relections were reserved for the calculation of Rfree.
Calculated with Molprobity.54
Non-crosslinked wild-type CDO diffraction data (0.15° oscillation images for a total of 114°) were collected at SSRL beamline 12–2 at a wavelength of 0.9795 Å at 100 K using Blu-Ice. The exposure time per frame was 0.4 s with 73.5% attenuation and a crystal to detector distance of 359.1 mm. The data was indexed and scaled with XDS to 2.30 Å. The crystals were assigned to the space group P4^2 with unit cell dimensions a = b = 57.6 Å and c = 122.5 Å (Table 1).
C93E CDO diffraction data (0.4° oscillation images for a total of 360°) were collected remotely on SSRL beamline 7–1 at a wavelength of 1.1271 Å at 100 K using Blu-Ice. The exposure time per frame was 5.71 s with 2.2% attenuation and a crystal to detector distance of 243.6 mm. The data was indexed and scaled with XDS to 1.91 A. The crystals were assigned to the space group P41212 with unit cell dimensions a = b = 57.7 Å and c = 122.2 Å (Table 1).
Molecular replacement calculations were performed using Phaser in the PHENIX program suite, using PDB: 2B5H as the search model with iron and waters removed yielding a clear solution with each structure.4,32 Log likelihood gains ranged from 2282 − 9483 with TFZ scores of 48 − 94. Model building and refinement were performed using Coot and Phenix Refine.32,33 Root mean square deviation (RMSD) calculations were obtained with lsqkab from ccp4.33 The final structure for wild-type CDO includes residues 6–190 with no missing intervening residues, 1 Fe, and 5 water molecules with 97.8% of the residues in favored Ramachandran angles and the remaining 0.2% in allowed regions. The structure of non-crosslinked wild-type CDO includes residues 6–190 with 99.5% of the residues in favored regions of the Ramachandran plot and the remaining 0.5% in allowed regions, 1 Fe and 19 water molecules. The structure of C93E CDO consists of residues 6189, 1 Fe, 1 acetate ion, and 84 water molecule with 99.4% of the residues with favorable Ramachandran angles and 0.6% in the allowed regions. None of the structures contain any residues with unfavorable Ramachandran angles; however, all three structures contain a single residue change E46D from the published structure (PDB: 4FX0). E46D is an external, solvent exposed residue, and this is likely an artifact of the cloning source.
Results
Characterization of wild-type and C93E CDO
Purified wild-type and C93E CDO enzymes were evaluated for crosslink formation by SDS-PAGE (Supplemental Figure S1). Wild-type CDO existed as a heterogeneous mixture of both non-crosslinked and crosslinked isoforms as seen previously; whereas, non-crosslinked CDO migrated as a single band similar to the higher molecular weight band seen in wild-type CDO.19,20 Because C93E CDO lacks the cysteine involved in formation of the thioether crosslink, the variant enzyme existed solely as the non-crosslinked isoform. Far-UV circular dichroism (CD) spectra of wild-type and C93E CDO were recorded to determine if the variant had altered overall gross secondary structure. The C93E CDO variant showed a comparable CD trace to crosslinked wild-type CDO (Supplemental Figure S2). The iron content of C93E CDO following dialysis was 50 ± 2% similar to non-crosslinked CDO at ~ 50% iron.20
Steady-state kinetic properties of wild-type and C93E CDO
Kinetic properties of wild-type and C93E CDO were determined by measuring the rate of dioxygen consumption using a Clark-type oxygen electrode (Supplemental Figure S3).28 The kcat/Km value for C93E CDO with L-cysteine as substrate was 450 ± 80 M−1 s−1 resulting in a ~78-fold decrease in oxygen consumption compared to wild-type (35,000 ± 6,000 M−1 s−1) (Table 2). Wild-type CDO is specific for L-cysteine, and has a reduced specificity constant for substrate analogs.24,34,35 Wild-type CDO showed kcat/Km values for D-cysteine of 1200 ± 600 M−1 s−1 and cysteamine of 1000 ± 300 M−1 s−1, and there was no oxygen consumed with 3-mercaptopropionic acid (Table 3). The kinetic parameters for C93E CDO were also determined with L-cysteine analogs to determine if alternative substrates could be utilized by the variant. For C93E CDO, the kcat/Km values were comparable, within error, with L-cysteine (450 ± 80), D-cysteine (300 ± 200M−1 s−1), or cysteamine (800 ± 300 M−1 s−1) as substrates (Table 2), and the variant showed no dioxygen consumption with 3-mercaptoproionic acid.
Table 2:
Steady-state kinetic parameters measuring oxygen consumption with L-cysteine.a
kcat (s−1) |
Km (μM) |
kcat/Km (M−1s−1) |
|
---|---|---|---|
wild-type CDOb | 2.1 ± 0.1 | 60 ± 10 | 35,000 ± 6,000 |
C93E CDO | 0.14 ± 0.02 | 320 ± 100 | 450 ± 80 |
Kinetic parameters adjusted for iron content.
Previously reported.21
Table 3:
Steady-state kinetic parameters measuring oxygen consumption with L-cysteine analogs.a
wild-type CDO | C93E CDO | |||||
---|---|---|---|---|---|---|
kcat (s−1) |
Km (mM) |
kcat/Km (M−1s−1) |
kcat (s−1) |
Km (mM) |
kcat/Km (M−1s−1) |
|
D-cysteine | 0.25 ± 0.02 | 0.2 ± 0.09 | 1200 ± 600 | 0.20 ± 0.03 | 0.7 ± 0.4 | 300 ± 200 |
cysteamine | 1.1 ± 0.1 | 1.1 ± 0.3 | 1000±300 | 1.2 ± 0.2 | 1.6 ± 0.6 | 800 ± 300 |
3-mercaptopropionate | –b | – | – | – | – | – |
Kinetic parameters adjusted for iron content.
There was no measurable activity under the described experimental conditions.
Analysis of cysteine sulfinic acid and hypotaurine product
Mass spectrometric analyses were performed to correlate product formation with dioxygen utilization utilizing L-cysteine and cysteamine. Wild-type CDO formed CSA from L-cysteine at a rate of 4000 ± 200 nmol min−1 mg−1, which correlated with 4300 ± 200 nmol min−1 mg−1 of O2 consumed (Table 4). Despite measured oxygen utilization, C93E CDO did not form CSA at detectable levels with L-cysteine as substrate. Because cysteamine lacks a carboxyl group, it may generate the product hypotaurine if cysteamine is able to bind monodentate to the metal center. When cysteamine was used as a substrate, both wild-type and C93E CDO exhibited comparable rates for dioxygen utilization. However, neither wild-type or C93E CDO were able to form hypotaurine.
Table 4:
Dioxygen utilization and cysteine sulfinic acid production of wild-type and C93E CDO with L-cysteine and cysteamine substrates.
L-cysteine | cysteamine | |||
---|---|---|---|---|
wild-type CDO | C93E CDO | wild-type CDO | C93E CDO | |
Dioxygen utilization (nmol/min/mg) | 4300 ± 200 | 270 ± 20 | 950 ± 20 | 1280 ± 10 |
Cysteine sulfinic acid production (nmol/min/mg) | 4000 ± 200 | --- | --- | --- |
EPR analyses of wild-type and C93E CDO
EPR analyses were performed to evaluate the coordination environment of the iron in the as purified and substrate bound state of C93E CDO. Previous EPR studies showed wild-type CDO as purified under our purification conditions to have a high spin iron (III) oxidation state with a g = 4.3 signal.29,35,37 However, the relative signal intensity has been shown to increase in the crosslinked isoform or with L-cysteine substrate bound.21,24,37 In addition, there is a shift to more rhombic iron(III) features with the resolution of three principal g-values with L-cysteine bound (gx,y,z=4.47, 4.36, and 4.27).24,37 Wild-type and C93E CDO existed in the high spin rhombic iron (III) oxidation state with an EPR signal of g = 4.46 for wild-type and g = 4.43 for C93E CDO (Figure 3A). The g-values observed for wild-type CDO in these studies in the absence of L-cysteine differed from those previously reported.21,24,29,35,38
Figure 3.
EPR spectra of wild-type and C93E CDO A. EPR spectra of wild-type (black trace) and C93E (blue trace) CDO. B. EPR spectra of C93E CDO (blue) with L-cysteine (red), cysteamine (green), and 3-MPA (gray). Spectra were taken with 100 μM protein in 25 mM HEPES buffer, pH 7.5, 10% glycerol, 100 mM sodium chloride.
C93E CDO was incubated in the presence of L-cysteine, cysteamine, or 3-MPA to evaluate the effects of substrate on the iron coordination environment. Compared to resting state C93E CDO, addition of substrates L-cysteine or 3-MPA resulted in an increase in the overall relative signal intensity, whereas there was no observable increase in the presence of cysteamine (Figure 3B). The g-values for cysteamine and L-cysteine with C93E CDO were comparable to the g-value obtained with C93E alone. There was a shift in the g-value for C93E CDO with 3-MPA to 4.38 compared to C93E CDO alone (g = 4.43). The shift in the g-value can be attributed to a change in the coordination environment of the iron center upon substrate binding.24
Three-dimensional structures of CDO
Crystal structures of crosslinked and non-crosslinked wild-type CDO were solved by molecular replacement and refined to 2.49 Å and 2.30 Å resolution, respectively. The C93E CDO variant was solved to 1.91 Å resolution. As anticipated, the structures show a high degree of similarity to the previously solved wild-type CDO structure (2B5H). The root mean square deviation (rmsd) for both wild-type CDO isoforms were similar to the previously determined wild-type CDO structure (PDB 2B5H) (Table 1). Similar rmsd values were also observed for the crosslinked and non-crosslinked wild-type CDO structures, and crosslinked wild-type CDO to C93E CDO (Table 1). The primary deviations were found in the active sites.
In both the crosslinked and non-crosslinked structures, the iron is coordinated by the three histidine residues and a water molecule in a tetrahedral coordination environment (Figure 4A and C). The iron in C93E CDO is also coordinated by the Nε-nitrogen on the imidazole ring of the same three histidine residues that coordinate the iron in wild-type CDO (Figure 4B). However, the Os-1 atom of Glu93 now forms a ligand to the iron center, and is occupying the site that has been proposed to coordinate dioxygen in the wild-type enzyme (Figure 4B)22,36,39,40 The other two coordination sites in the C93E CDO structure are occupied by a water and an acetate ion derived from the crystallization solution.
Figure 4.
Active site structures of CDO. A. The iron center of crosslinked wild-type CDO is coordinated by 3 His residues, and the thioether crosslink is formed between Cys93 and Tyr157 (blue, PDB: 6U4S). B. The iron center in the C93E CDO structure is coordinated by a 3His/1 Glu motif. The oxygen atom of acetate derived from the crystallization solution is also coordinating the metal center (salmon, PDB: 6U4L). C. The iron center of non-crosslinked CDO is coordinated by 3 His residues, but the thioether crosslink between Cys93 and Tyr157 has not formed (purple, PDB: 6U4V). The electron density maps are simulated annealing composite omit maps contoured at 2.0 σ.
An overlay of crosslinked and non-crosslinked wild-type CDO active sites shows little deviation in the His ligands coordinating the active site metal center (Figure 5A). The Tyr157 that forms the thioether adduct in crosslinked CDO has shifted 1.4 Å away from Cys93 in the non-crosslinked structure. C93E CDO exists as the homogeneous non-crosslinked isoform due to the substitution of Cys93 with Glu. This allows for coordination of Glu93 to the iron center (2.1 Å). Tyr157 in the C93E CDO structure is similarly shifted 1.4 Å away from Glu93 due to the absence of a thioether crosslink, akin to the distance between Tyr157 and Cys93 in the non-crosslinked wild-type CDO structure. In the C93E CDO structure the bound water is displaced relative to the coordinating water in both the crosslinked and non-crosslinked wild-type CDO structures. In the C93E CDO structure there is also a slight shift in His88 away from the active site (0.6 Å) that shifts the iron in the active site resulting in a shift in His86 (0.4 Å). All of the other distances are within error to both the crosslinked and non-crosslinked structures.
Figure 5.
Overlay of the active sites. A. The non-crosslinked CDO ligands are shown in purple and the cros slinked CDO ligands are shown in blue. Tyr157 in non-crosslinked CDO has shifted 1.4 Å away from Cys93 compared to Tyr157 in crosslinked CDO. B. The C93E CDO ligands are shown in salmon and the cros slinked wild-type CDO ligands are shown in blue. Absence of the thioether crosslink shifts the hydroxyl group of Tyr157 1.4 Å away Glu93 compared to the Tyr157 in wild-type CDO.
Discussion
In 3-His/1-Glu cupin dioxygenases, single-site substrate coordination to the iron is not uncommon. Initial studies of cupin proteins identified two conserved motifs that were thought to be a defining feature among this superfamily.3,41 Due to the extensive number of enzymes that belong to the cupin superfamily, it is difficult to determine the prevalence of this 3-His/1-Glu motif. As additional cupin proteins were identified, the idea of a defined conserved motif that defines the cupin family began to shift. Quercetin dioxygenase, an enzyme that catalyzes the first step in the degradation of quercetin, adopts the 3-His/1-Glu cupin motif. Both quercetin and dioxygen bind monodentate to the metal cation in a sequential ordered mechanism. It is important that quercetin only occupies one coordination site because bidentate binding of quercetin would occupy all metal sites leaving no room for dioxygen binding. In addition, monodentate binding of the bulky substrate allows it to remain flexible so unique distortion can occur, which is essential for oxygen incorporation and product formation.9 This monodentate binding of both substrates is a common mechanism for cupins with a 3-His/1-Glu metal binding site. While there are clearly enzymes that utilize a 3-His/1-Glu motif for metal coordination, other coordination geometries have also been identified within this family (3-His, 2-His/1-Glu, 2-His/1-Glu/1-Gln, and and 4- Cys).42–45
CDO contains a 3-His iron coordination center that diverges from the 3-His/1-Glu metal coordination site originally proposed for cupin enzymes. Like QDO, CDO follows an ordered sequential mechanism in which CDO binds L-cysteine first followed by dioxygen. The L-cysteine substrate binds bidentate to the Fe(II) center by the amino and thiol groups, and the carboxyl group is stabilized by a nearby arginine residue and the hydroxyl of the tyrosine involved in the thioether crosslink.40 After L-cysteine coordinates, dioxygen binds monodentate occupying the remaining coordination site.24,39 For product formation in CDO, bidentate substrate coordination has been suggested to lower the reduction potential of Fe(II) so dioxygen can bind to the metal cation and form the Fe(III) peroxo intermediate.38,39 Although it is known that both atoms of dioxygen are incorporated in the final cysteine sulfinic acid product, it is still unclear whether the oxygen proximal or distal to the iron reacts with the sulfur first.46
The Glu that coordinates the metal in some cupin enzymes is replaced by a Cys (Cys93) in CDO that forms a thioether crosslink with Tyr157. The sulfur of the cysteine residue at position 93 is too distant to coordinate the iron center. There are several proposed functional roles for the Cys-Tyr crosslink. The thioether adduct has been proposed to contribute to the stabilization of the coordinated substrates. Stabilization of substrate may occur through a pre-ordering of the active site to promote catalysis.21 Crosslink formation has also been proposed to protect Cys93 from potentially detrimental side reactions.24,26 Cysteamine dioxygenase (ADO) is a eukaryotic thiol dioxygenase that shares ~16% amino acid sequence identity with CDO.47 ADO was recently shown to form a thioether crosslink similar to CDO, but the role of the crosslink in catalysis has not been fully evaluated.47 There are two distinct bacterial cupin 3-His iron thiol dioxygenases that differ in their substrate specificities. Although the bacterial thiol dioxygenases contain an active-site Tyr, they are unable to form the cross-link because a Gly residue is in a comparable position as the thioether Cys in mammalian CDO.36,48,49
As hypothesized, the substitution of Cys93 to a glutamate residue yielded the 3-His/1-Glu coordination environment exhibited by several cupin enzymes (Figure 4B).6 In the three-dimensional structure, the carboxylate oxygen of Glu93 is coordinating the iron at the proposed dioxygen binding site. The lack of the thioether crosslink shifted Tyr157 1.4 Å away from Cys93. Cys93 in the non-crosslinked CDO structure was in a similar position as Glu93 in the C93E CDO variant, and Cys93 remained unable to coordinate the metal due to the shorter side chain.23 A structure of the Y157F CDO variant unable to form the crosslink, showed Cys93 in a similar conformation as both the Cys in non crosslinked CDO and Glu in C93E CDO. The Tyr157 in C93S CDO variant shifted 1.0 Å away from the iron.23 There was a 1.0 Å shift in the Fh-Tyr157 and a rotation of the aromatic ring in a non-crosslinked CDO structure containing fluorinated Tyr157.50 It was noted that the rotation was likely due to the fluorinated Tyr. Substitution of the Gly bacterial MDO with Cys resulted in crosslink formation, but there was no activity observed.51 In the non-crosslinked structure of the G95C MDO variant the Cys had shifted the active site Tyr.51 Similarly, the shift of Tyr157 in the non-crosslinked structure away from Cys93 and the metal in the non-crosslinked structure of CDO would be unable to assist in stabilizing substrates. It should be noted that the hydroxyl of Tyr157 hydrogen bonds to the water liganded to the iron in the the wild-type CDO structure, but not the non-crosslinked or C93E CDO structures reported here. Previously, in variants unable to form the thioether crosslink, a chloride ion was hypothesized to replace the water molecule coordinated to the iron for crystals grown in the presence of 15 mM chloride.40 Chloride was proposed to act as a potential inhibitor under physiological conditions. In the structures reported here, there is insufficient evidence to model the water molecule coordinating the iron in the crosslinked CDO structure as a chloride ion, despite the structures being determined from crystal grown in 1 M LiCl.
Wild-type CDO in the absence of substrate exhibited a similar g-value (g = 4.46) previously observed for crosslinked CDO or L-cysteine bound CDO.24,37 Given that the EPR spectra was obtained in the absence of L-cysteine, the shift in g-value of wild-type CDO is likely attributed to the crosslinked species. EPR spectra of resting wild-type and C93E CDO showed comparable Fe(III) signals with different g-values (Figure 3A) The difference in g-values in the absence of L-cysteine could be attributed to altered coordination of the iron center (3-His versus 3-His/1Glu).36 In the presence of L-cysteine the relative signal intensity C93E CDO increased compared to the resting state, but there was no apparent shift in g-values (Figure 3B). This change in signal intensity was previously observed with substrate binding and/or formation of the thioether crosslink.21,24,37 Given that the C93E CDO variant is unable to form the crosslink, the increased EPR signal observed for C93E CDO suggests L-cysteine is coordinating to the metal center (Figure 6A). The kcat/Km value for dioxygen utilization by C93E CDO was decreased ~78-fold compared to the wild-type enzyme with L-cysteine as substrate (Table 2), but the reduction of dioxygen was not coupled to oxidation of the L-cysteine thiol (Table 4). Therefore, the uncoupled dioxygen utilization observed in kinetic assays of C93E CDO suggests that dioxygen is also coordinating the metal center (Figure 6 B). This unproductive catalysis would produce reduced dioxygen uncoupled to L-cysteine substrate oxidation.39 Alternatively, the utilization of dioxygen uncoupled to product formation could be due to an to an outer sphere oxidation in the C93E CDO enzyme. The Cys93-Tyr157 thioether crosslink is essential for efficient coupling in wild-type CDO due to the positoning of Tyr157 in the active site that contributes to substrate recognition and enzyme-substrate stabilization.24 The absence of the crosslink could lead to a general instability in the active site resulting in the oxidation of active site amino acids.
Figure 6.
Putative binding models for C93E CDO. A. Bidentate binding of L-cysteine to C93E CDO. Bidentate binding of L-cysteine to C93E CDO would prevent dioxygen binding to the iron center. B. Monodentate binding of L-cysteine to C93E CDO. Monodentate binding of L-cysteine to C93E CDO could occur through coordination of the L-cysteine thiol or α-amino group of L-cysteine. C. Monodentate binding of L-cysteine to C93E CDO. D. Bidentate binding of 3-MPA to C93E CDO.
Analogs of L-cysteine were evaluated to determine if the 3-His/1-Glu iron coordination altered the substrate specificity. Substrate analogs D-cysteine and cysteamine displayed similar catalytic efficiencies for dioxygen consumption with C93E CDO, whereas 3-MPA had no measurable activity (Table 3). The activity did not correlate with product formation with cysteamine for C93E CDO, similar to results obtained with the L-cysteine substrate (Table 4). There are conflicting reports on the ability of wild-type CDO to utilize cysteamine. Several groups have been unable to detect product formation with cysteamine as substrate.35,36,52 However, alternative studies have identified cysteamine product formation with a coupling efficiency ~100-fold lower than with L-cysteine.53 When C93E CDO was incubated with cysteamine, the EPR g-value and signal intensity were comparable to the CDO variant in the absence of substrate, suggesting that cysteamine does not bind to the iron center. Cysteamine may bind with weak monodentate coordination of the sulfur or α-amino group to the metal center if substrate binding to the metal center is needed for dioxygen reduction (Figure 6 C). C93E CDO incubated in the presence of 3-MPA showed a shift in the g-value to 4.38 with an increase in the relative EPR signal intensity compared to C93E CDO with L-cysteine bound, supporting a more stable coordination of the substrate to the metal center. Bidentate binding of 3-MPA by the carboxylate group and thiol would prevent oxidation of the substrate thiol and dioxygen utilization observed with L-cysteine and cysteamine, and would also lead to the observed increase in the EPR signal intensity (Figure 6D).
These data lead to a connundrum. In the C93E CDO variant, where the glutamate replaces the putative dioxygen binding site, stable bidentate coordination of L-cysteine would prevent the binding of dioxygen, and activation of dioxygen by the ferrous iron.24 Therefore, the reduced kinetic parameters of the C93E CDO variant may indicate that the glutamate ligand must be broken at some point in the catalytic cycle, which is initiated by bidentate binding of the L-cysteine substrate followed by monodentate binding of dioxygen. While dioxygen is reduced, no product formation is detected, which may suggest the glutamate, even when not liganding the iron, sterically hinders chemistry. An alternative option is that the C93E CDO variant may be binding the L-cysteine substrate in a monodentate fashion allowing dioxgen to coordinate the reduced metal center at a site different than previously proposed, which is now occupied by the glutamate ligand (Figure 6B). This allows for reduction of dioxygen that is uncoupled from L-cysteine oxidation. However, it is not clear whether the α-amino group or thiol L-cysteine is coordinating the metal.
Conclusions:
The evolutionary divergence of the 3-His/1-Glu to a 3-His coordination environment in cysteine dioxygenase allows for multi-site occupancy of L-cysteine. Without the bidentate coordination, the L-cysteine substrate may remain too flexible for proper cysteine oxidation to occur. The Glu to Cys variation at residue 93 provides a third free coordination site on the ferric iron and opens the active site sterically to allow for simultaneous binding of cyteine in a bidentate fashion and dioxygen in a monodentate fashion.
Supplementary Material
Acknowledgements
Research reported in this publication was made possible by funds from the National Institute of Health (R01 GM127665) and National Science Foundation (CHE-1904494 and CHE-1403293) to ALL. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the NIH and NIGMS (including P41GM103393). Thank you to the staff at the SSRL for their generous assistance.
Footnotes
Accession Codes
cysteine dioygenase: Uniprot entry, P21816. PDB: 6U4S (crosslinked wild-type CDO), 6U4V (non-crosslinked wild-type CDO), 6U4L (C93E CDO).
acireductone dioxygenase: Uniprot entry, Q9ZFE7. PDB: 2HJI.
Supporting Information
Figure S1: SDS-PAGE of wild-type and C93E CDO.
Figure S2: Circular dichroism spectra of wild-type and C93E CDO.
Figure S3: Steady-state kinetic plots of wild-type and C93E CDO.
References
- 1.Sorbo B; Ewetz L (1965) The enzymatic oxidation of cysteine to cysteinesulfinate in rat liver in Biochem Biophys Res Commun 18, 359–363. [DOI] [PubMed] [Google Scholar]
- 2.Ewetz L; Sorbo B (1966) Characteristics of the cysteinesulfinate-forming enzyme system in rat liver in Biochim Biophys Acta 128, 296–305. [DOI] [PubMed] [Google Scholar]
- 3.Dunwell JM; Khuri S; Gane PJ (2000) Microbial relatives of the seed storage proteins of higher plants: conservation of structure and diversification of function during evolution of the cupin superfamily in Microbiol Mol Biol Rev 64, 153–179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.McCoy JG; Bailey LJ; Bitto E; Bingman CA; Aceti DJ; Fox BG; Phillips GNJ (2006) Structure and mechanism of mouse cysteine dioxygenase in Proc Natl Acad Sci USA 103, 3084–3089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Simmons CR; Liu Q; Huang Q; Hao Q; Begley TP; Karplus PA; Stipanuk MH (2006) Crystal structure of mammalian cysteine dioxygenase. A novel mononuclear iron center for cysteine thiol oxidation in J Biol Chem 281, 18723–18733. [DOI] [PubMed] [Google Scholar]
- 6.Gane PJ; Dunwell JM; Warwicker J (1998) Modeling based on the structure of vicilins predicts a histidine cluster in the active site of oxalate oxidase in J Mol Evol 46, 488–493. [DOI] [PubMed] [Google Scholar]
- 7.Oka T; Simpson FJ (1971) Quercetinase, a dioxygenase containing copper in Biochem Biophys Res Commun 43, 1–5. [DOI] [PubMed] [Google Scholar]
- 8.Dai Y; Wensink PC; Abeles RH (1999) One protein, two enzymes in J Biol Chem 274, 1193–1195. [DOI] [PubMed] [Google Scholar]
- 9.Schaab MR; Barney BM; Francisco WA (2006) Kinetic and spectroscopic studies on the quercetin 2,3-dioxygenase from Bacillus subtilis in Biochemistry 45, 1009–1016. [DOI] [PubMed] [Google Scholar]
- 10.Moomaw EW; Angerhofer A; Moussatche P; Ozarowski A; García-Rubio I; Richards NG (2009) Metal dependence of oxalate decarboxylase activity in Biochemistry 48, 6116–6125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Uberto R; Moomaw EW (2013) Protein similarity networks reveal relationships among sequence, structure, and function within the Cupin superfamily in PLoS One 8, e74477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Dunwell JM; Purvis A; Khuri S (2004) Cupins: the most functionally diverse protein superfamily in Phytochemistry 65, 7–17. [DOI] [PubMed] [Google Scholar]
- 13.Woo EJ; Dunwell JM; Goodenough PW; Marvier AC; Pickersgill RW (2000) Germin is a manganese containing homohexamer with oxalate oxidase and superoxide dismutase activities in Nat Struct Biol 7, 1036–1040. [DOI] [PubMed] [Google Scholar]
- 14.Ju T; Goldsmith RB; Chai SC; Maroney MJ; Pochapsky SS; Pochapsky TC (2006) One protein, two enzymes revisited: a structural entropy switch interconverts the two isoforms of acireductone dioxygenase in J Mol Biol 363, 823–834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Al-Mjeni F; Ju T; Pochapsky TC; Maroney MJ (2002) XAS investigation of the structure and function of Ni in acireductone dioxygenase in Biochemistry 41, 6761–6769. [DOI] [PubMed] [Google Scholar]
- 16.Koehntop KD; Emerson JP; Que L (2005) The 2-His-1-carboxylate facial triad: a versatile platform for dioxygen activation by mononuclear non-heme iron(II) enzymes in J Biol Inorg Chem 10, 87–93. [DOI] [PubMed] [Google Scholar]
- 17.Chai SC; Jerkins AA; Banik JJ; Shalev I; Pinkham JL; Uden PC; Maroney MJ (2005) Heterologous expression, purification, and characterization of recombinant rat cysteine dioxygenase in J Biol Chem 280, 9865–9869. [DOI] [PubMed] [Google Scholar]
- 18.Simmons CR; Hirschberger LL; Machi MS; Stipanuk MH (2006) Expression, purification, and kinetic characterization of recombinant rat cysteine dioxygenase, a non-heme metalloenzyme necessary for regulation of cellular cysteine levels in Protein Expr Purif 47, 74–81. [DOI] [PubMed] [Google Scholar]
- 19.Stipanuk MH; Londono M; Hirschberger LL; Hickey C; Thiel DJ; Wang L (2004) Evidence for expression of a single distinct form of mammalian cysteine dioxygenase in Amino Acids 26, 99–106. [DOI] [PubMed] [Google Scholar]
- 20.Dominy JE; Hwang J; Guo S; Hirschberger LL; Zhang S; Stipanuk MH (2008) Synthesis of amino acid cofactor in cysteine dioxygenase is regulated by substrate and represents a novel post-translational regulation of activity in J Biol Chem 283, 12188–12201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Njeri CW; Ellis HR (2014) Shifting redox states of the iron center partitions CDO between crosslink formation or cysteine oxidation in Arch Biochem Biophys 558, 61–69. [DOI] [PubMed] [Google Scholar]
- 22.Ye S; Wu X; Wei L; Tang D; Sun P; Bartlam M; Rao Z (2007) An insight into the mechanism of human cysteine dioxygenase. Key roles of the thioether-bonded tyrosine-cysteine cofactor in J Biol Chem 282, 3391–3402. [DOI] [PubMed] [Google Scholar]
- 23.Driggers CM; Kean KM; Hirschberger LL; Cooley RB; Stipanuk MH; Karplus PA (2016) Structure-based insights into the role of the Cys-Tyr crosslink and inhibitor recognition by mammalian cysteine dioxygenase in J Mol Biol 428, 3999–4012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Li W; Blaesi EJ; Pecore MD; Crowell JK; Pierce BS (2013) Second-sphere interactions between the C93-Y157 cross-link and the substrate-bound Fe site influence the O(2) coupling efficiency in mouse cysteine dioxygenase in Biochemistry 52, 9104–9119. [DOI] [PubMed] [Google Scholar]
- 25.Arjune S; Schwarz G; Belaidi AA (2015) Involvement of the Cys-Tyr cofactor on iron binding in the active site of human cysteine dioxygenase in Amino Acids 47, 55–63. [DOI] [PubMed] [Google Scholar]
- 26.Davies CG; Fellner M; Tchesnokov EP; Wilbanks SM; Jameson GN (2014) The Cys-Tyr cross-link of cysteine dioxygenase changes the optimal pH of the reaction without a structural change in Biochemistry 53, 7961–7968. [DOI] [PubMed] [Google Scholar]
- 27.Dominy JEJ; Hwang J; Guo S; Hirschberger LL; Zhang S; Stipanuk MH (2008) Synthesis of amino acid cofactor in cysteine dioxygenase is regulated by substrate and represents a novel post-translational regulation of activity in J Biol Chem 283, 12188–12201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Leitgeb S; Nidetzky B (2008) Structural and functional comparison of 2-His-1- carboxylate and 3-His metallocentres in non-haem iron(II)-dependent enzymes in Biochem Soc Trans 36, 1180–1186. [DOI] [PubMed] [Google Scholar]
- 29.Imsand EM; Njeri CW; Ellis HR (2012) Addition of an external electron donor to in vitro assays of cysteine dioxygenase precludes the need for exogenous iron in Arch Biochem Biophys 521, 10–17. [DOI] [PubMed] [Google Scholar]
- 30.Vanoni MA; Edmondson DE; Zanetti G; Curti B (1992) Characterization of the flavins and the iron-sulfur centers of glutamate synthase from Azospirillum brasilense by absorption, circular dichroism, and electron paramagnetic resonance spectroscopies in Biochemistry 31, 4613–4623. [DOI] [PubMed] [Google Scholar]
- 31.McPhillips TM; McPhillips SE; Chiu HJ; Cohen AE; Deacon AM; Ellis PJ; Garman E; Gonzalez A; Sauter NK; Phizackerley RP; Soltis SM; Kuhn P (2002) Blu-Ice and the Distributed Control System: software for data acquisition and instrument control at macromolecular crystallography beamlines in J Synchrotron Radiat 9, 401–406. [DOI] [PubMed] [Google Scholar]
- 32.Kabsch W (2010) XDS in Acta Crystallogr D Biol Crystallogr 66, 125–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Adams PD; Grosse-Kunstleve RW; Hung LW; Ioerger TR; McCoy AJ; Moriarty NW; Read RJ; Sacchettini JC; Sauter NK; Terwilliger TC (2002) PHENIX: building new software for automated crystallographic structure determination in Acta Crystallogr D Biol Crystallogr 58, 1948–1954. [DOI] [PubMed] [Google Scholar]
- 34.Emsley P; Cowtan K (2004) Coot: model-building tools for molecular graphics in Acta Crystallogr D Biol Crystallogr 60, 2126–2132. [DOI] [PubMed] [Google Scholar]
- 35.Chai SC; Bruyere JR; Maroney MJ (2006) Probes of the catalytic site of cysteine dioxygenase in J Biol Chem 281, 15774–15779. [DOI] [PubMed] [Google Scholar]
- 36.Dominy JE; Simmons CR; Karplus PA; Gehring AM; Stipanuk MH (2006) Identification and characterization of bacterial cysteine dioxygenases: a new route of cysteine degradation for eubacteria in JBacteriol 188, 5561–5569. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Crawford JA; Li W; Pierce BS (2011) Single turnover of substrate-bound ferric cysteine dioxygenase with superoxide anion: enzymatic reactivation, product formation, and a transient intermediate in Biochemistry 50, 10241–10253. [DOI] [PubMed] [Google Scholar]
- 38.Pierce BS; Gardner JD; Bailey LJ; Brunold TC; Fox BG (2007) Characterization of the nitrosyl adduct of substrate-bound mouse cysteine dioxygenase by electron paramagnetic resonance: electronic structure of the active site and mechanistic implications in Biochemistry 46, 8569–8578. [DOI] [PubMed] [Google Scholar]
- 39.Simmons CR; Krishnamoorthy K; Granett SL; Schuller DJ; Dominy JEJ; Begley TP; Stipanuk MH; Karplus PA (2008) A putative Fe2+-bound persulfenate intermediate in cysteine dioxygenase in Biochemistry 47, 11390–11392. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Driggers CM; Cooley RB; Sankaran B; Hirschberger LL; Stipanuk MH; Karplus PA (2013) Cysteine dioxygenase structures from pH 4 to 9: consistent cys-persulfenate formation at intermediate pH and a Cys-bound enzyme at higher pH in J Mol Biol 425, 3121–3136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Dunwell JM; Culham A; Carter CE; Sosa-Aguirre CR; Goodenough PW (2001) Evolution of functional diversity in the cupin superfamily. Trends Biochem Sci 26, 740–746. [DOI] [PubMed] [Google Scholar]
- 42.Levin EJ; Kondrashov DA; Wesenberg GE; Phillips GN (2007) Ensemble refinement of protein crystal structures: validation and application in Structure 15, 1040–1052. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Just VJ; Stevenson CE; Bowater L; Tanner A; Lawson DM; Bornemann S (2004) A closed conformation of Bacillus subtilis oxalate decarboxylase OxdC provides evidence for the true identity of the active site in J Biol Chem 279, 19867–19874. [DOI] [PubMed] [Google Scholar]
- 44.Cleasby A; Wonacott A; Skarzynski T; Hubbard RE; Davies GJ; Proudfoot AE; Bernard AR; Payton MA; Wells TN (1996) The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution in Nat Struct Biol 3, 470–479. [DOI] [PubMed] [Google Scholar]
- 45.Kruidenier L; Chung CW; Cheng Z; Liddle J; Che K; Joberty G; Bantscheff M; Bountra C; Bridges A; Diallo H; Eberhard D; Hutchinson S; Jones E; Katso R; Leveridge M; Mander PK; Mosley J; Ramirez-Molina C; Rowland P; Schofield CJ; Sheppard RJ; Smith JE; Swales C; Tanner R; Thomas P; Tumber A; Drewes G; Oppermann U; Patel DJ; Lee K; Wilson DM (2012) A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response in Nature 488, 404–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Lombardini JB; Singer TP; Boyer PD (1969) Cysteine oxygenase. II. Studies on the mechanism of the reaction with 18oxygen in J Biol Chem 244, 1172–1175. [PubMed] [Google Scholar]
- 47.Wang Y; Griffith WP; Li J; Koto T; Wherritt DJ; Fritz E; Liu A (2018) Cofactor Biogenesis in Cysteamine Dioxygenase: C-F Bond Cleavage with Genetically Incorporated Unnatural Tyrosine in Angew Chem Int Ed Engl 57, 8149–8153. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Driggers CM; Hartman SJ; Karplus PA (2015) Structures of Arg- and Gln-type bacterial cysteine dioxygenase homologs in Protein Sci 24, 154–161. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Pierce BS; Subedi BP; Sardar S; Crowell JK (2015) The “Gln-Type” thiol dioxygenase from Azotobacter vinelandii is a 3-mercaptopropionic acid dioxygenase in Biochemistry 54, 7477–7490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Li J, Koto T, Davis I and Liu A (2019) Probing the Cys-Tyr Cofactor Biogenesis in Cysteine Dioxygenase by the Genetic Incorporation of Fluorotyrosine in Biochemistry 58, 2218–2227. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Fellner M; Aloi S; Tchesnokov EP; Wilbanks SM; Jameson GN (2016) Substrate and pH-Dependent Kinetic Profile of 3-Mercaptopropionate Dioxygenase from Pseudomonas aeruginosa in Biochemistry 55, 1362–1371. [DOI] [PubMed] [Google Scholar]
- 52.Yamaguchi K; Hosokawa Y; Kohashi N; Kori Y; Sakakibara S; Ueda I (1978) Rat liver cysteine dioxygenase (cysteine oxidase). Further purification, characterization, and analysis of the activation and inactivation in JBiochem 83, 479–491. [DOI] [PubMed] [Google Scholar]
- 53.Li W; Pierce BS (2015) Steady-state substrate specificity and O2-coupling efficiency of mouse cysteine dioxygenase in Arch Biochem Biophys 565, 49–56. [DOI] [PubMed] [Google Scholar]
- 54.Williams C; Hintze BJ; Headd JJ, Moriarty NW, Chen VB, Jain S; Prisant MG; Lewis SM, Videau LL: Keedy DA; Deis LN; Arendall WB III; Verma V; Snoeyink JS; Adams PD; Lovell SC; Richardson JS; Richardson DC (2018) MolProbity: More and better reference data for improved all-atom structure validation in Prot Sci 27 293–315. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.